Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2

To compare single-agent pemetrexed (P) versus the combination of carboplatin and pemetrexed (CP) in first-line therapy for patients with advanced non-small-cell lung cancer (NSCLC) with an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 2. In a multicenter phase III randomized t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology 2013-08, Vol.31 (23), p.2849-2853
Hauptverfasser: ZUKIN, Mauro, BARRIOS, Carlos H, DA ROCHA BALDOTTO, Clarissa Serodio, METON VIEIRA, Fernando, SMALL, Isabele A, FERREIRA, Carlos G, LILENBAUM, Rogerio C, PEREIRA, Jose Rodrigues, DE ALBUQUERQUE RIBEIRO, Ronaldo, DE MENDONCA BEATO, Carlos Augusto, DO NASCIMENTO, Yeni Neron, MURAD, Andre, FRANKE, Fabio A, PRECIVALE, Maristela, DE LIMA ARAUJO, Luiz Henrique
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!